Old Web
English
Sign In
Acemap
>
authorDetail
>
Takafumi Matsushima
Takafumi Matsushima
Takeda Pharmaceutical Company
Medicine
Internal medicine
Population
Surgery
Tolerability
4
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer
2015
Cancer Chemotherapy and Pharmacology
Kazuhiro Suzuki
Seiichiro Ozono
Akito Yamaguchi
Hidekazu Koike
Hiroshi Matsui
Masao Nagata
Takatoshi Takubo
Kana Miyashita
Takafumi Matsushima
Hideyuki Akaza
Show All
Source
Cite
Save
Citations (2)
Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma
2014
Cancer Science
Michinori Ogura
Kensei Tobinai
Kiyohiko Hatake
Kenichi Ishizawa
Naokuni Uike
Toshiki Uchida
Tatsuya Suzuki
Tomohiro Aoki
Takashi Watanabe
Dai Maruyama
Masahiro Yokoyama
Takatoshi Takubo
Hideaki Kagehara
Takafumi Matsushima
Show All
Source
Cite
Save
Citations (42)
Phase 1 Study of the Investigational Proteasome Inhibitor Ixazomib Alone or in Combination with Lenalidomide–Dexamethasone (Rd) in Japanese Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM)
2014
Blood
Hiroshi Handa
Kenshi Suzuki
Takaaki Chou
Takafumi Matsushima
Show All
Source
Cite
Save
Citations (3)
Clinical Significance of Granulocytic Sarcoma at Relapse In Adult Patients with Acute Myeloid Leukemia
2010
Blood
Hiroaki Shimizu
Takayuki Saitoh
Takumi Hoshino
Naoko Hatsumi
Satoru Takada
Hiroyuki Irisawa
Akihiko Yokohama
Takahiro Jimbo
Hiroshi Handa
Takafumi Matsushima
Toru Sakura
Norifumi Tsukamoto
Masamitsu Karasawa
Hirokazu Murakami
Shuichi Miyawaki
Show All
Source
Cite
Save
Citations (0)
1